Coegin Pharma AB (COEGIN)

Currency in SEK
3.07
-0.02(-0.65%)
Closed·
COEGIN Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 13 days
COEGIN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.823.08
52 wk Range
2.508.86
Key Statistics
Prev. Close
4.65
Open
3
Day's Range
2.82-3.08
52 wk Range
2.5-8.86
Volume
3.57K
Average Volume (3m)
23.84K
1-Year Change
-55.76%
Book Value / Share
0.79
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
COEGIN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Coegin Pharma AB Company Profile

Coegin Pharma AB, a biotechnology company, engages in developing peptide-based products for hair growth and skin pigmentation in Sweden. The company develops Follicopeptide, a peptide designed to enhance hair growth; and NPP-4, a natural pigmentation peptide 4 works by facilitating the transport of melanin to the skin, mimicking the natural process that occurs during sun exposure or tanning beds. It is also developing FOL026, a drug candidate which is in preclinical trial for the treatment of myocardial infarction; AVX420, a drug candidate which is in preclinical trial for the treatment of leukemia; and AVX001, a drug candidate which is in phase 2 clinical development to treat both actinic keratosis and basal cell carcinoma. Coegin Pharma AB was founded in 2005 and is based in Lund, Sweden.

Compare COEGIN to Peers and Sector

Metrics to compare
COEGIN
Peers
Sector
Relationship
P/E Ratio
−3.4x−11.3x−0.5x
PEG Ratio
−0.05−0.210.00
Price/Book
3.9x5.9x2.6x
Price / LTM Sales
-69.4x3.3x
Upside (Analyst Target)
191.3%106.0%43.4%
Fair Value Upside
Unlock20.1%7.1%Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

COEGIN Income Statement

FAQ

What Stock Exchange Does Coegin Pharma AB Trade On?

Coegin Pharma AB is listed and trades on the Nordic Growth Market stock exchange.

What Is the Stock Symbol for Coegin Pharma AB?

The stock symbol for Coegin Pharma AB is "COEGIN."

What Is the Coegin Pharma AB Market Cap?

As of today, Coegin Pharma AB market cap is 76.37M.

What Is Coegin Pharma AB's Earnings Per Share (TTM)?

The Coegin Pharma AB EPS (TTM) is -1.02.

When Is the Next Coegin Pharma AB Earnings Date?

Coegin Pharma AB will release its next earnings report on 20 Aug 2025.

From a Technical Analysis Perspective, Is COEGIN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Coegin Pharma AB Stock Split?

Coegin Pharma AB has split 2 times.

How Many Employees Does Coegin Pharma AB Have?

Coegin Pharma AB has 1 employees.

What is the current trading status of Coegin Pharma AB (COEGIN)?

As of 08 Aug 2025, Coegin Pharma AB (COEGIN) is trading at a price of 3.07, with a previous close of 4.65. The stock has fluctuated within a day range of 2.82 to 3.08, while its 52-week range spans from 2.50 to 8.86.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.